i follow space carefully
AC8 remains best exposure - significantly lower market cap than CAN
catalyst will be announcements on import / export which will allow the Canopy Growth products into australia and able to be sold under SAS scheme
This will propel sector and stock for those positioned but AC8 has the platform right via the medical outreach program that will facilitate take up
sales q1 next year possible, stock will be 50% higher i suspect
no idea in when pullback from last weeks highs will end but this is key name in sector
- Forums
- ASX - By Stock
- AC8
- Morning Star Fair Value Estimate 1.40
Morning Star Fair Value Estimate 1.40, page-2
-
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable